Zenith Drugs Shareholding

Zenith Drugs Ltd Shareholding Pattern

The Zenith Drugs Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Zenith Drugs Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Zenith Drugs Ltd (NSE: ZENITHDRUG, BSE: 92356) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Zenith Drugs Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Zenith Drugs Ltd Shareholding Pattern (Latest)

The latest Zenith Drugs Ltd shareholding for Sept 2025 is:

• Promoters: 69.98%
• FII: 0%
• DII: 0%
• Public: 30.02%
• Government: 0%

Promoter holding in Zenith Drugs Ltd remains stable, reflecting consistent long-term commitment.

Zenith Drugs Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Zenith Drugs Ltd.

• Sept 2025: 69.98%
• Mar 2025: 69.98%
• Sept 2024: 69.98%
• Mar 2024: 69.98%
• Sept 2023: 100%

Promoter stake remains largely stable, showing consistent ownership structure.

Zenith Drugs Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Zenith Drugs Ltd.

• Sept 2025: 0%
• Mar 2025: 0.06%
• Sept 2024: 0.42%
• Mar 2024: 5.81%
• Sept 2023: 0%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Zenith Drugs Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Sept 2025: 0%
• Mar 2025: 0%
• Sept 2024: 0%
• Mar 2024: 0%
• Sept 2023: 0%

DII holdings remain stable, reflecting steady institutional participation.

Zenith Drugs Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Sept 2025: 30.02%
• Mar 2025: 29.96%
• Sept 2024: 29.60%
• Mar 2024: 24.21%
• Sept 2023: 0%

Public participation in Zenith Drugs Ltd has increased, indicating rising retail investor interest.

Zenith Drugs Ltd Government Holding

Government holding in Zenith Drugs Ltd currently stands at 0%.

Zenith Drugs Ltd operates without significant government ownership.

Zenith Drugs Ltd Shareholding Analysis Summary

The Zenith Drugs Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Zenith Drugs Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Zenith Drugs Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.